Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
271
Views
30
CrossRef citations to date
0
Altmetric
Review

Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients

Guohua Zhu1 Guizhou Medical University, Guiyang, Guizhou Province550002, People’s Republic of China;2 Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province550002, People’s Republic of China
,
Jukun Song2 Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province550002, People’s Republic of China;3 Guizhou University School of Medicine, Guiyang, Guizhou Province550025, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2542-9340
ORCID Icon,
Weimin Chen3 Guizhou University School of Medicine, Guiyang, Guizhou Province550025, People’s Republic of China
,
Dongbo Yuan2 Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province550002, People’s Republic of China;3 Guizhou University School of Medicine, Guiyang, Guizhou Province550025, People’s Republic of China
,
Wei Wang2 Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province550002, People’s Republic of China
,
Xiaoyue Chen3 Guizhou University School of Medicine, Guiyang, Guizhou Province550025, People’s Republic of China
,
Hen Liu2 Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province550002, People’s Republic of China;4 Zunyi Medical University, Zunyi, Guizhou Province563000, People’s Republic of China
,
Hao Su2 Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province550002, People’s Republic of China;4 Zunyi Medical University, Zunyi, Guizhou Province563000, People’s Republic of China
&
Jianguo Zhu1 Guizhou Medical University, Guiyang, Guizhou Province550002, People’s Republic of China;2 Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province550002, People’s Republic of China;3 Guizhou University School of Medicine, Guiyang, Guizhou Province550025, People’s Republic of China;4 Zunyi Medical University, Zunyi, Guizhou Province563000, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1171-0126
ORCID Icon show all
Pages 659-675 | Published online: 25 Jan 2021

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vineeth Sukrithan, Marium Husain, Lawrence Kirschner, Manisha H. Shah & Bhavana Konda. (2021) Emerging drugs for the treatment of adrenocortical carcinoma. Expert Opinion on Emerging Drugs 26:2, pages 165-178.
Read now

Articles from other publishers (29)

Baiyinzi Du, Shudan Luo, Xujun Zhu, Maqing Hu, Xianzhang Feng, Qianjun Yu, Bin Bai, Jian Xu & Jun Wang. (2024) WAY-262611 ameliorates the inflammatory bowel disease by activating Wnt/β-catenin pathway. In Vitro Cellular & Developmental Biology - Animal 60:2, pages 128-138.
Crossref
Xiaoya Sun, Yujie Deng, Man Ni, Tao Zhang, Xinqi Wang, Ye Wu, Zongwen Shuai & Faming Pan. (2024) Aberrant DNA Methylation Profile of Dickkopf-1 in Ankylosing Spondylitis. Biochemical Genetics.
Crossref
Mariz Kasoha, Anna K. Steinbach, Rainer M. Bohle, Barbara Linxweiler, Bashar Haj Hamoud, Merle Doerk, Meletios P. Nigdelis, Lisa Stotz, Julia S. M. Zimmermann, Erich-Franz Solomayer, Askin C. Kaya & Julia C. Radosa. (2024) Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients. Cancers 16:2, pages 419.
Crossref
Huisheng Li, Chao Wu, Zhenxing Sun, Xin Yu, Weishuai Liu, Dongying Liu & Ping Li. (2023) DKK1 Impairs the Tumor Response to αPD‐1 Immunotherapy by Inactivating CD8 + T Cells and Recruiting MDSC Cells in HNSC . Advanced Therapeutics 6:12.
Crossref
Shiyu Yuan, Nathan K. Hoggard, Noriko Kantake, Blake E. HildrethIIIIII & Thomas J. Rosol. (2023) Effects of Dickkopf-1 (DKK-1) on Prostate Cancer Growth and Bone Metastasis. Cells 12:23, pages 2695.
Crossref
Xinyu Zhai, Xinglin Chen, Jianyi Gu, Dongdong Guo, Xiangyang Zhan, Mingyue Tan & Dongliang Xu. (2023) The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma. Frontiers in Oncology 13.
Crossref
Madhuri Jayathirtha, Taniya Jayaweera, Danielle Whitham, Brîndușa Alina Petre, Anca-Narcisa Neagu & Costel C. Darie. (2023) Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography–Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpression. International Journal of Molecular Sciences 24:19, pages 14714.
Crossref
Jian Li, Yaqiong Zhang, Fangzhou Ye, Peiyu Qian, Zhe Qin, Deming Li, Li Ye & Li Feng. (2023) DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway. Cancers 15:19, pages 4756.
Crossref
Qilong Zhang, Mingyuan Zhao, Shuangyan Lin, Qi Han, He Ye, Fang Peng & Li Li. (2023) Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC. Heliyon 9:8, pages e18503.
Crossref
Rebecca Arend, Jhalak Dholakia, Cesar Castro, Ursula Matulonis, Erika Hamilton, Camille Gunderson Jackson, Kristopher LyBarger, Howard M. Goodman, Linda R. Duska, Haider Mahdi, Adam C. ElNaggar, Michael H. Kagey, Amy Liu, Diane Piper, Lisa M. Barroilhet, William Bradley, Jasgit Sachdev, Cynthia A. Sirard, David M. O'Malley & Michael Birrer. (2023) DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma. Gynecologic Oncology 172, pages 82-91.
Crossref
Yung-Chien Hsu, Cheng-Chih Chang, Ching-Chuan Hsieh, Yu-Ting Huang, Ya-Hsueh Shih, Hsiu-Ching Chang, Pey-Jium Chang & Chun-Liang Lin. (2023) Dickkopf-1 Acts as a Profibrotic Mediator in Progressive Chronic Kidney Disease. International Journal of Molecular Sciences 24:8, pages 7679.
Crossref
Rui Mu, Yuehong Shen, Chuanbin Guo, Xinyun Zhang, Hongyu Yang & Huijun Yang. (2023) Seven Immune-Related Genes’ Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma. Mediators of Inflammation 2023, pages 1-17.
Crossref
Woo-Jung Park & Moon Jong Kim. (2023) A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities. Cells 12:8, pages 1110.
Crossref
Xinyu Ye, Jingwen Liu, Rencui Quan, Yi Lu & Jian Zhang. (2023) DKK1 affects survival of patients with head and neck squamous cell carcinoma by inducing resistance to radiotherapy and immunotherapy. Radiotherapy and Oncology 181, pages 109485.
Crossref
Dakota Doucet, Connor Brubaker, Donald Turner & Carl A. Gregory. (2023) Factors affecting the role of canonical Wnt inhibitor Dickkopf-1 in cancer progression. Frontiers in Oncology 13.
Crossref
Edward J. Jarman, Marta Horcas‐Lopez, Scott H. Waddell, Stephanie MacMaster, Konstantinos Gournopanos, Daniel Y. H. Soong, Kamila I. Musialik, Panagiota Tsokkou, Minn‐E Ng, William A. Cambridge, David H. Wilson, Michael H. Kagey, Walter Newman, Jeffrey W. Pollard & Luke Boulter. (2022) DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN ‐01 . Liver International 43:1, pages 208-220.
Crossref
Kristin Frensemeier, Angela Holzer, Karin Hoppe‐Seyler & Felix Hoppe‐Seyler. (2022) Dickkopf‐1 expression is repressed by oncogenic human papillomaviruses ( HPVs) and regulates the Cisplatin sensitivity of HPV ‐positive cancer cells in a JNK ‐dependent manner . International Journal of Cancer 151:12, pages 2215-2228.
Crossref
Po-Wei Su & Bor-Sen Chen. (2022) Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications. International Journal of Molecular Sciences 23:22, pages 13869.
Crossref
Zi-Ning Lei, Qiu-Xu Teng, Qin Tian, Wei Chen, Yuhao Xie, Kaiming Wu, Qianlin Zeng, Leli Zeng, Yihang Pan, Zhe-Sheng Chen & Yulong He. (2022) Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduction and Targeted Therapy 7:1.
Crossref
Shuang Ma & Fei Chen. (2022) Common strategies for effective immunotherapy of gastroesophageal cancers using immune checkpoint inhibitors. Pathology - Research and Practice 238, pages 154110.
Crossref
Amir Salehi, Lixiao Wang, Philip J. Coates, Lena Norberg Spaak, Xiaolian Gu, Nicola Sgaramella & Karin Nylander. (2022) Reiterative modeling of combined transcriptomic and proteomic features refines and improves the prediction of early recurrence in squamous cell carcinoma of head and neck. Computers in Biology and Medicine 149, pages 105991.
Crossref
Anne Olbrich, Olga Gros, Sebastian Ebel, Timm Denecke, Holger Gößmann, Nicolas Linder, Florian Lordick, Dirk Forstmeyer, Daniel Seehofer, Robert Sucher, Sebastian Rademacher, Johannes Niemeyer, Madlen Matz-Soja, Thomas Berg & Florian van Bömmel. (2022) Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular Carcinomas. Cancers 14:19, pages 4807.
Crossref
Umair Ali Khan Saddozai, Fengling Wang, Saadullah Khattak, Muhammad Usman Akbar, Muhammad Badar, Nazeer Hussain Khan, Lu Zhang, Wan Zhu, Longxiang Xie, Yongqiang Li, Xinying Ji & Xiangqian Guo. (2022) Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma. Cells 11:18, pages 2924.
Crossref
Xiaoyan Wang, Yun Zhou, Chunfu Wang, Yanyan Zhao, Yan Cheng, Suhuai Yu, Xiaofeng Li, Wenjing Zhang, Ying Zhang & Huiqin Quan. (2022) HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC. Clinical and Translational Oncology 24:10, pages 1998-2009.
Crossref
Cristina Antohi, Mihaela Salceanu, Liana Aminov, Maria-Alexandra Martu, Cristina Gena Dascalu, Gianina Dodi, George Stoica, Geanina Bandol, Dragos Iancu, Bogdan Dobrovat & Danisia Haba. (2022) Assessment of Systemic and Maxillary Bone Loss in Cancer Patients with Endo-Periodontal Lesions Using Dkk-1 Biomarker and Dental Radiological Examinations. Applied Sciences 12:10, pages 5235.
Crossref
A. ElNaggar, N. Zhang, C.B. Scalise, C. Sirard, M.H. Kagey, D. Vaena & R. Arend. (2022) Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report. Gynecologic Oncology Reports 39, pages 100904.
Crossref
Daniel Martin Klotz, Theresa Link, Maren Goeckenjan, Pauline Wimberger, Anna R. Poetsch, Nikolai Jaschke, Lorenz C. Hofbauer, Andy Göbel, Tilman D. Rachner & Jan Dominik Kuhlmann. (2022) Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients. Clinical Chemistry and Laboratory Medicine (CCLM) 60:1, pages 109-117.
Crossref
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, Fengfei Xie, Deependra Tyagi, Yunjiao He & Peng George Wang. (2021) Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy. Cells 10:11, pages 2957.
Crossref
Jiang Jiang, Jianfang Li, Weiwu Yao, Wenfang Wang, Bowen Shi, Fei Yuan, Jingyan Dong & Huan Zhang. (2021) FOXC1 Negatively Regulates DKK1 Expression to Promote Gastric Cancer Cell Proliferation Through Activation of Wnt Signaling Pathway. Frontiers in Cell and Developmental Biology 9.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.